Results 131 to 140 of about 10,767 (163)

Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors. [PDF]

JCO Precis Oncol
Oller A, Kemmeren P, Perotti D, van Tinteren H, Verschuur A, Spreafico F, Brok J, Furtwängler RCJ, Chowdhury T, Al-Saadi R, Vujanic GM, Treece AL, Drost J, van Grotel M, Mullen EA, Evageliou NF, Graf N, Hong AL, Gessler M, Geller JI, van den Heuvel-Eibrink MM.   +20 more
europepmc   +1 more source

The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers. [PDF]

Cancer Res
Federico A, Gopisetty A, Surdez D, Iddir Y, Autry RJ, Waterfall JJ, Saberi-Ansari E, Bobin C, Ballet S, Pierron G, Wierzbinska JA, Schlicker A, Sill M, Volckmann R, Zwijnenburg DA, Mackay A, Zaïdi S, Saint-Charles A, Mack N, Schwalm B, Brabetz S, Weiser L, Buchhalter I, Previti C, Böttcher AL, Iradier F, Rief EM, Jones DTW, Witt O, Westermann F, Milde T, Eggert A, Huebener N, Schulte JH, Colombetti S, Chesler L, Tucker ER, Morcavallo A, Lorenzi F, Kovar H, Klusmann JH, Debatin KM, Bomken S, Guttke CD, Hamerlik P, Hattersley MM, Garcia M, Colland F, Strougo A, Aviles P, Zapotocky M, Sumerauer D, Gojo J, Berger W, Lötsch-Gojo D, Schueler J, Girard EJ, Olson JM, Schäfer BW, Wachtel M, Molenaar JJ, Dumevska B, Fernandez Potente E, Jones C, Carcaboso AM, Indersie E, Cairo S, Scotlandi K, Manara MC, Landuzzi L, Di Giannatale A, Gasparini P, Moro M, Gürgen D, Hoffmann J, Marques da Costa ME, Geoerger B, Delattre O, Shields DJ, Caron HN, Vassal G, Stancato LF, Pfister SM, Jäger N, Koster J, Kool M, Schleiermacher G.   +86 more
europepmc   +1 more source

Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumor. [PDF]

Cell Rep
Fleming AM, Jablonowski CM, Jin H, Zhang S, Sona S, Lee HW, Dieseldorff Jones KM, Cheng C, Xu B, Morton CL, Woolard MA, Pichavaram P, Gehle DB, Natarajan S, Kodali K, Pagala V, High AA, Kumar Y, Burden S, Valentine V, Daria D, Harbour J, Vocelle D, Chang TC, Easton J, Olsen SR, Neale G, Pinto EM, Rehg JE, Janke L, Santiago T, George RE, Ma X, Zambetti GP, Davidoff AM, Chen T, Wu G, Chen X, Yang J, Murphy AJ.   +39 more
europepmc   +1 more source

Preoperative neutrophil-to-lymphocyte ratio as an early risk-stratification and prognostic biomarker in Wilms tumor: a retrospective study. [PDF]

Front Oncol
Feng D, Zhang C, Li J, Chen L, Qi C.
europepmc   +1 more source

Estimation of Detailed Cardiac Doses for Pediatric Radiation Therapy Patients in National Wilms Tumor Study. [PDF]

Int J Radiat Oncol Biol Phys
Lee C, Mille MM, Griffin KT, Rigsby C, Popescu A, Gopalakrishnan M, Leisenring W, Peterson S, Dome JS, Laurie F, Fitzgerald TJ, Bentzen S, Jung JW, Lee C, Kalapurakal JA.   +14 more
europepmc   +1 more source

Correction: Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors. [PDF]

Front Oncol
Hargrave D, Marshall LV, André N, Krystal J, Ladle BH, Robbins KA, Hois S, Armstrong J, Donegan S.   +8 more
europepmc   +1 more source

FBXW7-Related Neurodevelopmental Disorder: Clinical Spectrum, Molecular Mechanisms, and Tumor Predisposition. [PDF]

Hum Mutat
Savasta S, Comisi FF, Fiumicelli E, Dell'Isola GB, Di Pasquale G, Mangano GD, Zagaroli L, Salpietro V, Verrotti A.   +8 more
europepmc   +1 more source

Pathogenic germline variations and cancer risks in pediatric patients referred for genetic testing. [PDF]

Nat Med
Wang H, Dong X, Xiao F, Li G, Lu Y, Qiao M, Wu B, Ni Q, Yan K, Li Q, Yin Z, Yang L, Chen D, Chen L, Kang W, Wei Q, Tao L, Cheng G, Wang L, Li K, Shen C, Wang S, Xu X, Yang M, Liu F, Li H, Zhang K, Zhou W, International Consortium in Digital Twins in Healthcare and Medicine.   +28 more
europepmc   +1 more source